INO - Inovio Stock Continues To Surge: What's Going On? | Benzinga
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading higher again on Wednesday after surging more than 40% on Tuesday after the FDA said it can use data from the completed Phase 1/2 trial of INO-3107 to submit a Biological License Application (BLA) for accelerated approval.
What Happened: Inovio received feedback from the FDA that data from a recent trial can be used to make a submission for the FDA's accelerated approval ...